The present invention discloses a synergistic topical formulation comprising a combination of Alclometasone and Nadifloxacin along with pharmaceutically acceptable excipients for treatment on of dermatoses, acne vulgaris caused by Propionibacterium acne and Staphylococcus species and sycosis vulgaris. ...

Disclosed herein is pharmaceutical composition comprising combination of Etodolac with Paracetamol in a solid dosage form along with the pharmaceutically acceptable excipients useful for the treatment of pain, inflammation in the body caused by osteoarthritis and rheumatoid arthritis.

The present invention discloses a liquid pharmaceutical composition for omprising a therapeutically effective amount of myorelaxant, particularly thiocholchicoside, alongwith pharmaceutically acceptable excipients for oral administration.

The present invention discloses a novel drug delivery system for proton pump inhibitors comprising benzimidazole compounds or their salts,preferably Rabeprazole or its and pharmaceutically acceptable excipients in powder form which is reconstitutable ina parenterally acceptable solvent to form an injectable solution...

The present invention discloses a novel pharmaceutical combination having etoricoxib, thiocolchicoside and methyl salicylate alongwith pharmaceutically acceptable excipients. The said combination is helpful in alleviating pain and muscular spasms in patients suffering from Osteoarthritis, Rheumatoid Arthritis, soft...

ABSTRACT: Disclosed herein is the topical pharmaceutical composition comprising combination of Halometasone monohydrate and antifungal drug such as Miconazole nitrate or Clotrimazole along with pharmaceutically acceptable excipients, for treatment of infective eczema and eradicating fungal infections and further it...

Disclosed herein is a Controlled Porosity Osmotic Pump (CPOP) system for water soluble drug such as Trimetazidine dihydrochloride or pharmaceutically acceptable salts thereof, useful for the treatment of angina pectoris. Also disclosed herein is the process for preparation of controlled porosity osmotic pump tablet ...

Disclosed herein, topical composition comprising Alclometasone with Fusidic Acid or its pharmaceutical salt, Sodium Fusidate, along with pharmaceutically acceptable excipient useful for the management of corticosteroid responsive dermatoses, psoriasis, eczema and edema of groin or armpits.

Disclosed herein is a stable sustained release liposomal injection comprising Citicoiine entrapped in the ammonium sulfate liposomes, useful to enhance brain uptake efficiency,

The invention provides a Diacerein oral dispersible tablet formulation comprising diluents, disintegrants, film formers, binders, flavours, sweeteners, lubricants, and/or glidants. The said pharmaceutical formulation is particularly useful for Osteoarthritis.

The present invention describes stable herbal topical compositions comprises volatile oils like Peppermint ka tel (Mentha oil; Oil of Mentha Piperata), Nilgiri ka tel (Eucalyptus oil; Oil of leaves of plant Eucalyptus globulus), Wintergreen oil (Methyl Salicylate or oil extracted from leaves of plant Goultheria Proc...

Disclosed herein is pharmaceutical composition comprising of a COX-II inhibitor and a muscle relaxant in combination which is useful in the treatment of management of pain and pain related disorders and symptoms. Particularly the present invention discloses pharmaceutical composition comprising etoricoxib and tizani...

The present invention discloses a topical formulation for treatment of eczematous reaction comprising a combination of corticosteroid and an anti-fungal agent. Particularly, the present invention discloses a topical formulation comprising a combination of Alclometasone dipropionate and Miconazole nitrate along with ...

The invention disclosed herein is an oral pharmaceutical composition comprising combination of Etodolac and Thiocolchicoside; along with pharmaceutically acceptable exicipients, and process for preparation thereof.

Disclosed herein is topical composition comprising corticosteroid such as Halobetasol Propionate along with bacteriostatic antibiotic agent such as Fusidic acid or its pharmaceutical salt Sodium fusidate, along with pharmaceutically acceptable excipients in the form of cream and ointment useful for the management of...

Disclosed herein is topical composition comprising therapeutically effective amount of corticosteroid Halobetasol Propionate and broad-spectrum anti-bacterial agent Nadifloxacin along with one or more pharmaceutically acceptable excipients for the treatment of infective dermatoses, infective eczema, atopic der...

Disclosed herein is mouth dissolving pharmaceutical compositions of Rimonabant which comprises Rimonabant in the range of 60 % -10% w/w croscarmellose sodium in the range of 1.5 % -5.0 ww %weight; microcrystalline cellulose (Avicel PH 101/Avicel PH 102) in the range of 10 %-50% w/w; sodium starch glycollate in the r...

Disclosed herin is granular phrmaceutical formulation comprising citicoline, also known as CDP-choline or cytidine diphosphate choline and a physiologically acceptable acidic ingerdiennt along with pharmaceutically acceptable excipients, formulated for despersion in water prior to administration. ...

The present invention discloses an emergency contraceptive formulation for nasal and/or pulmonary administration comprising of levonorgestrel, optionally in combination with ethylestradiol. The said formulation can be in form of solution, suspension or carrier based systems selected from microemulsion and liposomes....

The invention disclosed herein is an oral pharmaceutical composition comprising combination of Citicoline and Vinpocetine along with pharmaceutically acceptable excipients, useful for the treatment of variety of CNS disorders, and process for preparation thereof.

The invention disclosed herein is a topical pharmaceutical composition comprising combination of Sertaconazole nitrate with at least one synthetic corticosteroid selected from Halobetasol propionate or Alclometasone dipropionate along with pharmaceutically acceptable excipients, useful for the effective treatment of...

The invention disclosed herein is a fixed dose pharmaceutical composition comprising combination of Citicoline sodium equivalent to Citicoline and Piracetam along with pharmaceutically acceptable excipients, useful for the treatment of dementia which appears due to senility or Alzheimer"s disease and chronic cerebra...

Disclosed herein are synergistic pharmaceutical parenteral compositions having broad spectrum antibacterial activity comprising combinations of Cephalosporins and Beta-Lactamase inhibitors. More particularly, the invention describes parenteral composition wherein the Cephalosporins are Cefepime, Ceftazidime and Cefo...

The invention discloses a pharmaceutical composition comprising therapeutically effective amount of stimulants, anti-motion drugs and nootropics, either alone or in combination, administered through, oral, intranasal or intravenous, for the treatment and/or management of dyslexia

The controlled released composition comprises Itopride or its pharmaceutically acceptable salts, rate controlling ploymer and one or more pharmaceutically acceptable excipients. Further the invention discloese a process for preparation of controlled relese compositions of Itopride or its pharmaceuticallly acceptable...

The invention discloses a topical anti-inflammatory formulation comprising a myorelaxant in combination with rubefacient and a counter-irritating agent. The invention particularly discloses a topical anti-inflammatory formulation comprising thiocholchicoside, methyl salicylate and menthol in form of gel or ointment ...

The invention disclosed herein is the liquid formulation comprising therapeutically effective amount of Choline Alfoscerate in an amount of 100mg to 500mg /5ml, along with pharmaceutically accepted excipients such as sugar alcohol, co-solvents, flavours, colours and preservatives, wherein said liquid formulation opt...

Disclosed herein is a novel pharmaceutical solid oral dosage form comprising Citicoline and folic acid in a therapeutically effective amount along with pharmaceutically acceptable excipients; useful for the treatment of neurodegenerative disorders. The invention also relates to process for preparation thereof. ...

The present invention discloses a novel pharmaceutical formulation comprising a combination of alclometasone and mupiriocin alongwith pharmaceutically acceptable excipients for treatment of infectious eczematoid dermatitis.

The invention disclosed herein is a topical pharmaceutical composition comprising combination of Halobetasol propionate and Tazarotene along with pharmaceutically acceptable excipients, useful for the treatment of different types of psoriasis and also discloses the process for preparation thereof. ...

A stable topical non-aqueous gel formulation comprising NSAID, particularly Aceclofenac, methyl salicylate and linseed oil useful for the treatment of relief of pain and inflammation associated with acute musculo-skeletal pain in adults like backache, arthritis, strains and sprains etc.

The present invention relates to liquid pharmaceutical composition in the form of palatable syrup for the treatment patients with cerebral injuries of vascular or traumatic origin, memory loss, chronic cerebral vascular insufficiency and degenerative changes in senile dementia. The liquid pharmaceutical composition ...

The present invention discloses a stable microemulsion based topical cream formulation for administration of alclometasone. The said formulation comprises an emollient, an oleaginous vehicle, an emulsifying agent and an oil base as microemulsion forming components alongwith other pharmaceutically acceptable excipien...

The present invention discloses an efficacious topical cream formulation containing halobetasol solubilized in oleaginous vehicle as discontinuous phase, a surfactant or emulsifying agent and an aqueous continuous phase. The said formulation shows improved permeation characteristics

N/A

Novel formulation of NSAIDS in liquid or semi solid from for rectal use with drug delivery system wherein the said formulation comprises active ingredient, NSAIDS like refecoxib, paracetamol, nimesulide, valdecoxib and their pharmaceutical analogues; one or more water miscible and non greasy solvents like purified w...

Topical formulation comprising therapeutically effective amount of Etodolac, Methyl Salicylate, and Menthol along with pharmaceutically acceptable excipients in the form of gel and emulgel; useful for relief of pain and inflammation in patients suffering form Osteoarthritis, Rheumatoid arthritis, soft tissue Rheumat...

The present invention discloses a stable microemulsion based topical cream formulation containing Halometasone monohydrate. The said formulation comprises an emollient, an oleaginous vehicle, an emulsifying agent and an oil base as microemulsion forming components alongwith other pharmaceutically acceptable excipien...

The present invention discloses a novel Controlled Porosity Osmotic Release (CPOR) delivery system for controlled release of highly water soluble drugs wherein the controlled porosity of the membrane is accomplished by the use of different channeling agents in varying proportions in the coating solution. The present...

The invention provides Stable compositions comprising Pregabalin wherein the Pregabalin content in the composition is 8%w/w of the total composition and comprises Carbomer (Carbomer Homopolymer Type C) as a gelling agent. The invention additionally provides a process to prepare the stable Pregabalin 8% w/w compositi...